β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion
Summary: Interleukin-1 receptor antagonist (IL-1Ra) is elevated in the circulation during obesity and type 2 diabetes (T2D) but is decreased in islets from patients with T2D. The protective role of local IL-1Ra was investigated in pancreatic islet β cell (βIL-1Ra)-specific versus myeloid-cell (myelo...
Main Authors: | Marianne Böni-Schnetzler, Stéphanie P. Häuselmann, Elise Dalmas, Daniel T. Meier, Constanze Thienel, Shuyang Traub, Friederike Schulze, Laura Steiger, Erez Dror, Praxedis Martin, Pedro L. Herrera, Cem Gabay, Marc Y. Donath |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-02-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124718301128 |
Similar Items
-
Pancreatic α Cell-Derived Glucagon-Related Peptides Are Required for β Cell Adaptation and Glucose Homeostasis
by: Shuyang Traub, et al.
Published: (2017-03-01) -
Increased CD34 in pancreatic islet negatively predict islet β-cell decrease in type1 diabetes model
by: Shichen Huang, et al.
Published: (2022-11-01) -
Incretin effect of Urena lobata leaves extract on structure and function of rats islet β-cells
by: Y. Purnomo, et al.
Published: (2017-07-01) -
Approaches to Inducing β-Cell Regeneration
by: Fred Levine
Published: (2022-02-01) -
β-Cell Replacement Strategies: The Increasing Need for a “β-Cell Dogma”
by: Andhira Vieira, et al.
Published: (2017-06-01)